
Ibyra contains Olaparib, a targeted cancer therapy known as a PARP inhibitor. It is used in the treatment of certain BRCA-mutated cancers, including ovarian, breast, prostate, and pancreatic cancers, by preventing cancer cells from repairing their DNA.
| Manufacturer | Cipla |
| Generic Name | Olaparib |
| Strength | 150mg |
| Package size | 60 Tablets |
| Used for | Ovarian, breast, pancreatic, and prostate cancers |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, UAE, Saudi Arabia, Qatar, Kuwait, and many other countries. |

Authentic Medicines

Fast Delivery

Secure Payment

24/7 Support
Olaparib is a PARP inhibitor that blocks DNA repair in cancer cells. This leads to accumulation of DNA damage, especially in BRCA-mutated cells, causing cancer cell death.
Dr. Ashish Kumar holds a Doctor of Medicine (MD) degree and has a professional interest in oncology and cancer care. His areas of interest include anticancer therapies, monitoring treatment response, managing treatment-related side effects and providing supportive care throughout treatment.
Disclaimer
All information on this website is for educational purposes only. Medicines should be used only with a doctor’s prescription and supervision. We do not provide medical advice, and product details may change without notice. Always consult a healthcare professional before using any medication.